[RNAZ] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[RNAZ] TransCode Therapeutics, Inc.
Announcement Date
31-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- -329.11%
YoY- -108.39%
Quarter Report
RNAZ's Result
RNAZ's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -5,300 -4,342 -4,817 -5,134 -4,290 -4,671 -3,470 32.59%
Tax 27 789 -5 13,275 655 -36 -7 -
NP -5,300 -4,342 -4,812 -18,409 -4,290 -4,635 -3,463 32.77%
Tax Rate - - - - - - - -
Total Cost 5,300 4,342 4,812 18,409 4,290 4,635 3,463 32.77%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -67.95 -135.68 -267.34 -1,134.84 -264.45 -289.70 -216.41 -53.77%
EPS Diluted -67.15 -131.61 -267.34 -1,134.84 -264.45 -285.73 -213.45 -53.71%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.